Damm, M., Efremov, L., Birnbach, B., Terrero, G., Kleeff, J., Mikolajczyk, R., . . . Krug, S. (2021). Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer—A Systematic Review and Meta-Analysis. Cancers, 13(17), 4326. https://doi.org/10.3390/cancers13174326
Citace podle Chicago (17th ed.)Damm, Marko, Ljupcho Efremov, Benedikt Birnbach, Gretel Terrero, Jörg Kleeff, Rafael Mikolajczyk, Jonas Rosendahl, Patrick Michl, a Sebastian Krug. "Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer—A Systematic Review and Meta-Analysis." Cancers 13, no. 17 (2021): 4326. https://doi.org/10.3390/cancers13174326.
Citace podle MLA (9th ed.)Damm, Marko, et al. "Efficacy and Safety of Neoadjuvant Gemcitabine Plus Nab-Paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Cancer—A Systematic Review and Meta-Analysis." Cancers, vol. 13, no. 17, 2021, p. 4326, https://doi.org/10.3390/cancers13174326.